Sort
40,608 grants matching “prostate cancer”
Interaction of Chemical Carcinogens and Chemotherapeutic Agents with DNA
$663,266Miriam C Poirier · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Aligning financial incentives to promote rational use of active surveillance for prostate cancer
$663,204Vahakn B Shahinian · University Of Michigan At Ann Arbor · R01 · FY2025 · CA
Single-use Microfluidic Device for Radiopharmaceutical Production
$663,092Henry Charles Manning · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · EB
Biological Functions of Chromosomal Proteins
$663,028Michael Bustin · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Epigenetic mechanisms of indole-3-carbinol/diindolylemthane and triterpenoids in prevention of prostate inflammation and related disease
$663,003Ah-Ng Tony Kong · Rutgers, The State Univ Of N.J. · R01 · FY2015 · AT
"DNMT and TET1 reprogramming as a targetable mechanism of resistance in advanced prostate cancer"
$662,893David S. Rickman · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA
DNA repair gene mutations and prostate cancer
$662,863Binghui Shen · Beckman Research Institute/City Of Hope · R01 · FY2024 · CA
Effect of Aerobic Exercise on Genomic Signatures of Prostate Cancer Prognosis
$662,769June Ml Chan · University Of California, San Francisco · R01 · FY2014 · CA
Extended Cancer Education for Longer-term Survivors (EXCELS) In Primary Care
$662,745Shawna V. Hudson · Rbhs-Robert Wood Johnson Medical School · R01 · FY2017 · CA
Hyperpolarized C-13 MRI Techniques to Monitor Radiation Therapy Response in Prostate Cancer Patients
$662,643Daniel B Vigneron · University Of California, San Francisco · R01 · FY2021 · CA
Epitomic Biomarkers of Prostate Cancer
$662,637University Of Michigan At Ann Arbor · U01 · FY2005 · CA
MESENCHYMAL STEM CELL-BASED THERAPY FOR PROSTATE CANCER
$662,500Brigham & Womens Hospital Inc · · FY2013 · Department of Defense
Uncovering causal protein markers to improve prostate cancer etiology understanding and risk prediction in Africans and Europeans
$662,482Lang Wu · University Of Hawaii At Manoa · R01 · FY2023 · CA
Early Detection and Diagnosis of Lung Cancer with Endomicroscopy
$662,413Melissa J Suter · Massachusetts General Hospital · R01 · FY2021 · CA
TARGETING PROSTATE CANCER WITH BIFUNCTIONAL MODULATORS OF THE ANDROGEN RECEPTOR
$662,362Regents Of The University Of Michigan · · FY2011 · Department of Defense
High throughput nanoplasmonic exosome testing (NEXT) of immunotherapies in bladder cancer
$662,338Cesar M Castro · Massachusetts General Hospital · R01 · FY2021 · CA
Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion
$662,120Ira Daar · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways
$662,120Ira Daar · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Biomarkers of Hormone Therapy Response in a Multicenter Prostate Cancer Trial
$662,099Amir Goldkorn · University Of Southern California · R01 · FY2018 · CA
Integrated omics analysis of clonal hematopoiesis and cardiovascular disease risk in TOPMed
$662,051Karen Conneely · Emory University · R01 · FY2023 · HL
MICELLAR DRUG DELIVERY AND PROTEOMICS ANALYSIS FOR EFFECTIVE TREATMENT OF RESISTANT PROSTATE CANCER.
$662,039Board Of Regents Of The University Of Nebraska · · FY2010 · Department of Defense
BKV and JCV vaccine development
$661,981Christopher Buck · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Culturally Adapted Cognitive Behavioral Stress and Self-Management (C-CBSM) Intervention for PC
$661,905Frank J Penedo · Northwestern University At Chicago · R01 · FY2016 · CA
A novel immunoPET imaging agent to guide treatment planning in lethal prostate cancer
$661,882Robert Richard Flavell · University Of California, San Francisco · R37 · FY2021 · CA
Optimizing prostate cancer care: integrating risks, benefits, and patient experiences in the new era of molecular imaging
$661,782Michael Stuart Leapman · Yale University · R01 · FY2025 · CA